Amgen, Takeda, UCB enrol first patient in Covid-19 global platform study

COMMUNITY is a placebo-controlled platform study designed to assess multiple candidates as a potential treatment for hospitalised patients with Covid-19. (Credit: fernando zhiminaicela from Pixabay)